Steven D Gore

Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation

Michael A McDevitt, J. Herman, M. McDevitt, 2010, Leukemia & lymphoma.

Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.

Wei Zhang, Jeanne Kowalski, Hua-Ling Tsai, 2009, Cancer research.

Epigenetics in Cancer: A Hematological Perspective

Tae Kon Kim, S. Gore, A. Zeidan, 2016, PLoS genetics.

MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.

Lucy Skrabanek, John M Greally, J. Licht, 2009, Blood.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.

Valeria Santini, Robert Schoch, Pierre Fenaux, 2009, The Lancet. Oncology.